Literature DB >> 6804142

Macrophages and protective immunity in Mycobacterium lepraemurium infections in a 'resistant' (C57Bl) and a 'susceptible' (BALB/c) mouse strain.

P M Preston.   

Abstract

The progressive low resistance form of M. lepraemurium infection in BALB/c mice and the more benign form of infection in C57Bl mice provided appropriate models for analysing the role of macrophages in the spectrum of leprosy in man. Although C57Bl mice were more resistant to both primary and challenge infections than BALB/c mice, peritoneal macrophages from infected mice of both strains were bacteriostatic in vitro. However, a diffusion chamber technique demonstrated that macrophages of BALB/c mice were usually less effective in controlling mycobacterial multiplication in vivo than those of C57Bl mice. This technique also revealed two diffusible factors in infected mice of both strains: one able to activate, the other able to suppress macrophage anti-mycobacterial activity. In C57Bl mice, the macrophage activating factor was apparently dominant; in BALB/c mice, the macrophage suppressor factor seemed to play the major role.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804142      PMCID: PMC1536546     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  LIMITED MULTIPLICATION OF ACID-FAST BACILLI IN THE FOOT-PADS OF MICE INOCULATED WITH MYCOBACTERIUM LEPRAE.

Authors:  R J REES
Journal:  Br J Exp Pathol       Date:  1964-04

2.  Classification of mouse leprosy.

Authors:  Y KAWAGUCHI
Journal:  Jpn J Exp Med       Date:  1959-12

3.  Macrophage proliferation in vitro induced by exudates.

Authors:  K M Wynne; W G Spector; D A Willoughby
Journal:  Nature       Date:  1975-02-20       Impact factor: 49.962

4.  Application of diffusion chamger technic to the cultivation of Mycobacterium lepraemurium. I. In vivo studies.

Authors:  T Ito; Y Kishi
Journal:  Int J Lepr Other Mycobact Dis       Date:  1972 Apr-Jun

5.  Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures.

Authors:  A C Allison; P D Hart
Journal:  Br J Exp Pathol       Date:  1968-10

6.  Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines.

Authors:  T Godal; R J Rees; J O Lamvik
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

7.  Leukocyte antimicrobial function in patients with leprosy.

Authors:  D J Drutz; M J Cline; L Levy
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

8.  Splenic regulation of cell-mediated immunity to Listeria monocytogenes.

Authors:  M K Poirot; R L Myers
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

9.  Serum from infected mice suppresses macrophage-mediated immunity in Mycobacterium lepraemurium infection: a model for imparied macrophage immunity in human leprosy.

Authors:  P M Preston
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

10.  Adoptive transfer of immunity and suppression by cells and serum in early Mycobacterium lepraemurium infections of mice.

Authors:  J Alexander
Journal:  Parasite Immunol       Date:  1979       Impact factor: 2.280

View more
  7 in total

1.  Resistance to subcutaneous infection with Mycobacterium lepraemurium is controlled by more than one gene.

Authors:  J Curtis; J L Turk
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

2.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.

Authors:  T J Holzer; K E Nelson; R G Crispen; B R Andersen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

3.  Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

4.  Enhancement of resistance in Mycobacterium lepraemurium infected C3H mice by treatment with sonicated M. lepraemurium or splenectomy.

Authors:  R Turcotte; J Chaput; S Lemieux
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

5.  Macrophage activity in resistant and susceptible mouse strains infected with Mycobacterium lepraemurium.

Authors:  S J Brett; R Butler
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

6.  Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Resistance to Mycobacterium lepraemurium is correlated with the capacity to generate macrophage activating factor(s) in response to mycobacterial antigens in vitro.

Authors:  S J Brett; R Butler
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.